MediLexicon Logo
MediLexicon Logo
Abbreviations        Abbrev Definitions        Dictionary        ICD Codes        Equipment        Hospitals        Drugs        More..
  


Testoderm TTS CIII

Company: Alza
Approval Status: Approved December 1997
Treatment for: testosterone deficiency
Areas: Diabetes / Endocrinology

| General Information | Clinical Results |


General Information

Testoderm TTS CIII has been approved for men with testosterone deficiency. It is a transdermal patch that delivers a 5-mg dose of testosterone during a 24-hour period.


Clinical Results

Clinical Results: Clinical trials showed that application of the Testoderm patch maintained normal serum testosterone levels, with delivery comparable to the normal circadian pattern of testosterone secretion.




< back to top

Testoderm TTS CIII Drug Information

The Testoderm Tts Ciii drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.





MediLexicon International Ltd Logo

Privacy Policy   |    Disclaimer   |    Contact / Feedback

MediLexicon International Ltd
Bexhill-on-Sea, UK
MediLexicon International Ltd © 2004-2014 All rights reserved.